Maternal and Infant Vaccines
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 20 September 2026 | Viewed by 1003
Special Issue Editors
2. Vaccinology and Immunology Research Trials Unit, Women’s and Children’s Hospital, Adelaide, SA 5006, Australia
Interests: health in pregnancy; maternal vaccination; infant health
2. Vaccinology and Immunology Research Trials Unit, Women’s and Children’s Hospital, Adelaide, SA 5006, Australia
Interests: vaccine effectiveness; vaccine attitudes; disease burden
Special Issue Information
Dear Colleagues,
Pregnancy and infancy are periods of increased vulnerability to infection. Vaccinating women during pregnancy has been shown to be effective in protecting against infections, while also providing protection for the fetus and the infant during early life. Vaccinating infants can be effective in protecting them from infections. This Special Issue on ‘Maternal and Infant Vaccines’ aims to collect recent evidence on vaccines administered to pregnant women and babies in the first year of life. We are pleased to invite you to submit manuscripts to this Special Issue related to the following themes:
- Uptake, safety and effectiveness of current vaccines;
- Immunogenicity of vaccines;
- Potential future vaccines that are currently undergoing clinical trials.
We look forward to receiving your contributions.
Dr. Prabha Andraweera
Dr. Bing Wang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- maternal vaccines
- infant vaccines
- immunogenicity
- effectiveness
- vaccine uptake
- safety
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
